We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$61.1B
AUM Growth
+$4.73B
(+8.4%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
2,331
New
154
Increased
918
Reduced
1,058
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Healthcare | 14.47% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Staples | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAVN
2026
DELISTED
Raven Industries Inc
RAVN
| $283K | ﹤0.01% |
7,372
-238
| -3% | -$8.89K |
|
2027
Compass Minerals
CMP
$1.13B
| $282K | ﹤0.01% |
4,502
-849
| -16% | -$54.3K |
|
2028
American Vanguard Corp
AVD
$65.5M
| $281K | ﹤0.01% |
13,792
-3,634
| -21% | -$69.2K |
|
|
FMBI
2029
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $281K | ﹤0.01% |
12,840
+1,345
| +12% | +$26.3K |
|
2030
AXT Inc
AXTI
$4.83B
| $280K | ﹤0.01% |
24,045
+3,397
| +16% | +$40.8K |
|
2031
Inseego
INSG
$87.7M
| $279K | ﹤0.01% |
2,793
| – | – |
|
2032
iShares MSCI India ETF
INDA
$6.6B
| $278K | ﹤0.01% |
+6,587
| New | +$276K |
|
2033
FirstEnergy
FE
$27.1B
| $277K | ﹤0.01% |
8,047
-3,071
| -28% | -$100K |
|
|
VBIV
2034
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $275K | ﹤0.01% |
2,946
-610
| -17% | -$61.9K |
|
2035
Revolve Group
RVLV
$1.73B
| $274K | ﹤0.01% |
6,097
-9,377
| -61% | -$382K |
|
2036
TripAdvisor
TRIP
$1.26B
| $274K | ﹤0.01% |
5,094
-211,603
| -98% | -$9.08M |
|
2037
Federal Signal
FSS
$7.74B
| $273K | ﹤0.01% |
7,127
+105
| +1% | +$3.8K |
|
|
LUNA
2038
DELISTED
Luna Innovations Incorporated
LUNA
| $272K | ﹤0.01% |
25,836
+5,193
| +25% | +$58.1K |
|
|
LTHM
2039
DELISTED
Livent Corporation
LTHM
| $271K | ﹤0.01% |
+15,670
| New | +$307K |
|
|
HES
2040
DELISTED
Hess
HES
| $270K | ﹤0.01% |
3,816
-20,409
| -84% | -$1.31M |
|
2041
Alnylam Pharmaceuticals
ALNY
$29B
| $269K | ﹤0.01% |
1,914
-37,733
| -95% | -$5.68M |
|
2042
Assembly Biosciences
ASMB
$530M
| $269K | ﹤0.01% |
4,870
-3,339
| -41% | -$221K |
|
|
CCF
2043
DELISTED
Chase Corporation
CCF
| $268K | ﹤0.01% |
2,304
-1,226
| -35% | -$137K |
|
2044
Cushman & Wakefield Ltd
CWK
$3.12B
| $266K | ﹤0.01% |
16,309
+1,580
| +11% | +$24.7K |
|
2045
Sportsman's Warehouse
SPWH
$46.4M
| $266K | ﹤0.01% |
15,409
-118,702
| -89% | -$2.07M |
|
|
RAD
2046
DELISTED
Rite Aid Corporation
RAD
| $260K | ﹤0.01% |
12,721
-14,863
| -54% | -$323K |
|
2047
Caledonia Mining Corp
CMCL
$439M
| $259K | ﹤0.01% |
18,112
+4,295
| +31% | +$66.1K |
|
|
SRCL
2048
DELISTED
Stericycle Inc
SRCL
| $258K | ﹤0.01% |
3,869
-2,563
| -40% | -$174K |
|
2049
Columbia Banking Systems
COLB
$8.84B
| $257K | ﹤0.01% |
5,973
-3,878
| -39% | -$169K |
|
2050
Axos Financial
AX
$5.63B
| $256K | ﹤0.01% |
+5,443
| New | +$245K |
|
Similar funds
VGA
AQR Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Capital Management held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AQR Capital Management's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- AQR Capital Management added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- AQR Capital Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- AQR Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- AQR Capital Management's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- AQR Capital Management opened 154 new positions and closed 154 in Q1 2021.
- AQR Capital Management's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.